Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Sehouli, J; Camara, O; Schmidt, M; Mahner, S; Seipelt, G; Otremba, B; Schmalfeldt, B; Tesch, H; Lorenz-Schlüter, C; Oskay-Ozcelik, G; North-Eastern German Society of Gynecological Oncology 
Titel:
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study. 
Abstract:
PURPOSE: Pegylated liposomal doxorubicin (PLD, CAELYX) has demonstrated activity in several phase-III trials and has been approved for the therapy of relapsed ovarian cancer after platinum treatment. Aim of this observational study was to analyze the efficacy and toxicity profile of PLD under routine clinical conditions and without the general restrictions of defined inclusion and exclusion criteria of clinical trials. METHODS: Between 2003 and 2005, a total of 190 patients with relapsed ovarian...    »
 
Zeitschriftentitel:
Cancer Chemother Pharmacol 
Jahr:
2009 
Band / Volume:
64 
Heft / Issue:
Seitenangaben Beitrag:
585-91 
Sprache:
eng 
Print-ISSN:
0344-5704 
TUM Einrichtung:
Frauenklinik und Poliklinik